Skip to content

A Prospective, Multicenter Observational Study to Access Safety of Herbal Medicines

A Prospective, Multicenter Observational Study to Access Safety of Herbal Medicines

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001279
Enrollment
1000
Registered
2014-11-18
Start date
2013-07-15
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Daejeon Korean Medicine Hospital of Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients over the age of 18 2) Patients who will be administered herbal medicine over two weeks 3) Patietns whose blood test(liver function and renal function test) is normal at baseline 4) Patients who has no psychological health issues 5) Patients who consent to involve this randomized clinical trial by themselves

Exclusion criteria

Exclusion criteria: 1) Patients who suffer chronic liver diseases(viral hepatitis, liver cirrhosis, liver cancer) 2) Patients who suffer chronic renal diseases(chronic renal failure, renal cell carcinoma) 3) Patients who have suffered toxic hepatitis 4) Patients who have cancers 5) Patients who suffer cardio-vascular, endocrine, blood and psychological diseases 6) Patients who have been taking western medicines over one months except blood pressure, diabetes mellitus, hyperlipidemia and anti-coagulation medicines 7) Patients who have been organ-transplanted or are taking immunosuppresants 8) Pregnant 9) Patients who have serious psychological diseases

Design outcomes

Primary

MeasureTime frame
Safety evaluation in patients who administered herbal medicine over two weeks

Secondary

MeasureTime frame
Physical examination;Blood and urine test regarding drug safety;Adverse events

Countries

Korea, Republic of

Contacts

Public ContactJung-Hyo Cho

Daejeon Korean Medicine Hospital of Daejeon University

choajoa@dju.kr+82-42-229-6806

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026